about
Customizing the genome as therapy for the β-hemoglobinopathiesMicroRNA Expression in β-Thalassemia and Sickle Cell Disease: A Role in The Induction of Fetal HemoglobinThe molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.α:Non-α and Gγ:Aγ globin chain ratios in thalassemia intermedia patients treated with hydroxyurea.Enhancement of β-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA.IthaGenes: an interactive database for haemoglobin variations and epidemiologyGenetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia.Hemoglobinopathy: molecular epidemiological characteristics and health effects on Hakka people in the Meizhou region, southern China.Stress erythropoiesis: new signals and new stress progenitor cells.Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approachVariants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the diseaseα-Globin as a molecular target in the treatment of β-thalassemiaGenetic modifiers of sickle cell diseaseβ-Globin chain abnormalities with coexisting α-thalassemia mutations.The prevention of thalassemia.Hemoglobin research and the origins of molecular medicine.Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.The First Report of a 290-bp Deletion in β-Globin Gene in the South of Iran.Sickle cell nephropathy - a practical approach.New updating into hemoglobinopathies.Association between sickle cell anemia and alpha thalassemia reveals a high prevalence of the α3.7 triplication in congolese patients than in worldwide series.Emerging cellular and gene therapies for congenital anemias.Molecular basis of β thalassemia and potential therapeutic targets.Prevalence of α(+)-Thalassemia in the Scheduled Tribe and Scheduled Caste Populations of Damoh District in Madhya Pradesh, Central India.Differential gene expression analysis in early and late erythroid progenitor cells in β-thalassaemia.Multiple Testing in the Context of Gene Discovery in Sickle Cell Disease Using Genome-Wide Association Studies.Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice.Recent advances in β-thalassemiasThe effect of Duffy antigen receptor for chemokines on severity in sickle cell disease.A novel (epsilongammadeltabeta)(o)-thalassemia deletion associated with an alpha globin gene triplication leading to a severe transfusion dependent fetal thalassemic syndrome.Molecular analysis of β-thalassemia patients: first identification of mutations HBB:c.93-2A>G and HBB:c.114G>A in Brazil.A reduced curcuminoid analog as a novel inducer of fetal hemoglobin.First reported duplication of the entire beta globin gene cluster causing an unusual sickle cell trait phenotype.Proteomic evaluation to identify biomarkers for carpal tunnel syndrome: a comparative serum analysis.Contribution of β-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults.The Frequency and Importance of Common α-globin Gene Deletions Among β-Thalassemia Carriers in an Iranian Population.Red blood cells free α-haemoglobin pool: a biomarker to monitor the β-thalassemia intermedia variability. The ALPHAPOOL study.Limitations of Hb F as a phenotypic modifier in sickle cell disease: study of Kuwaiti Arab patients.Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.Molecular analysis of complex cases of alpha- and beta-thalassemia in Mexican mestizo patients with microcytosis and hypochromia reveals two novel alpha(0) -thalassemia deletions - -(Mex1) and - -(Mex2).
P2860
Q26751061-2E17EFB4-FFAC-4A11-9341-DB0361DA3DB0Q26766931-BDE641B4-84B4-4A2C-97CD-2B4A6FC3183CQ33534066-D063EA42-7B82-4DA3-AD64-2149ABC3C6D7Q33628874-FD073289-E335-4F7D-A0F9-74AC018DD5A1Q33722582-A821639B-64D3-465E-B123-151BEEE5E0A3Q33945880-D11E9A2B-B5F7-4A61-9744-70627464D048Q34149136-D6DFAFC4-5FA7-4136-B93C-2A8C78132AE4Q34577052-97E0853D-0838-4123-A6B6-61B125D414A3Q34997232-C03DDC57-53BE-4B23-A808-396C37561834Q35087288-52B51880-C0D7-4AC5-BAE8-D9280EEB2878Q35528718-8B3488E5-5E6C-4B85-BB41-9A872E0BC869Q35836891-D6EC8919-D5D9-4E8B-B884-8C669D65B5FDQ36035471-E780D7B8-0AEC-4DD1-BBBA-64F74766A8D8Q36286247-902DA1C1-C544-42C6-A0A7-E8A14E405FB7Q36554628-E2257765-AA6A-4ACE-B042-76AE8D33C5EBQ36969792-9F73D715-AA8F-4DD9-AE21-A2413935B099Q37379477-E1F034E5-3706-4AC6-94D7-730FD6A9EC23Q37611369-BFA40E08-A29C-4FCC-82A2-062FD89FE9E7Q37929278-F308A585-59C0-480D-B3D6-D98F2431EDC1Q38023896-309D1D69-F817-4C22-B83A-357A5FCBE5EDQ38918877-B679FF32-145E-4973-9932-159D97992497Q38993825-6D8D964A-5348-4862-8D11-AE5D3B997F04Q39399184-2A0B5987-74E8-45CD-ACEE-0B7F059A6856Q40749436-F21845EA-0CCA-4E65-82A0-8156DACA816CQ41041947-F0173768-6BEF-4772-A3C8-847F5B801DE8Q41232448-C52E4674-E0DF-4DDF-8F4B-BCAEE0FE9209Q41785602-60D4A8B7-D04B-4294-9934-1F0657D595E4Q41973193-31D26E09-66CD-44EB-BD3D-FBA79CAE295EQ43065876-EB7329ED-904B-43E2-B79D-AB23D1DAAD62Q43152774-9CC42F4F-1920-4C16-B187-8FA2D1892352Q43496102-25391C20-42F8-484B-A704-6F39E9EC43BBQ44238537-7AA010BC-EC05-439E-8D2F-E7BDE7EF8A90Q45092825-4F8B5CC2-0A83-4E4D-8FE6-6C3D1FE4ECF0Q45358020-4D72579C-C401-4A87-B4AE-99CFCD9A9E51Q46342011-7F7ADAE3-50D9-4875-B406-D92107D08F5EQ47139024-5DCA0776-C47E-43DF-B066-AC884856190DQ48232409-0916FD98-14ED-4A31-9D9A-09AAD14D13EDQ48840343-070BDADA-7AE5-44B7-9042-F2D13BA45FE0Q50061134-093C6522-92F9-445D-B7A6-CDE0C48F9F12Q50201741-382380D5-D11C-4213-A9E7-9A03D3B6FC85
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic modifiers of the beta-haemoglobinopathies.
@en
Genetic modifiers of the beta-haemoglobinopathies.
@nl
type
label
Genetic modifiers of the beta-haemoglobinopathies.
@en
Genetic modifiers of the beta-haemoglobinopathies.
@nl
prefLabel
Genetic modifiers of the beta-haemoglobinopathies.
@en
Genetic modifiers of the beta-haemoglobinopathies.
@nl
P1476
Genetic modifiers of the beta-haemoglobinopathies.
@en
P2860
P304
P356
10.1111/J.1365-2141.2008.07084.X
P407
P577
2008-05-01T00:00:00Z